Supplemental Figure 2 from Mitochondrial Uncoupling Inhibits Reductive Carboxylation in Cancer Cells

Haowen Jiang,Clifford Jiajun He,Albert M. Li,Bo He,Yang Li,Meng-Ning Zhou,Jiangbin Ye

DOI: https://doi.org/10.1158/1541-7786.24229834

2023-01-01

Abstract:S2. Mitochondrial uncoupler NEN accelerates forward TCA cycle and inhibits reductive carboxylation.

What problem does this paper attempt to address?

Supplemental Figure 5 from Mitochondrial Uncoupling Inhibits Reductive Carboxylation in Cancer Cells

Haowen Jiang,Clifford Jiajun He,Albert M. Li,Bo He,Yang Li,Meng-Ning Zhou,Jiangbin Ye

DOI: https://doi.org/10.1158/1541-7786.23710121

2023-01-01

Abstract:S5. Mitochondrial uncoupler NEN, FCCP and BAM15 inhibit reductive carboxylation under hypoxia.
Supplemental Figure 8 from Mitochondrial Uncoupling Inhibits Reductive Carboxylation in Cancer Cells

Haowen Jiang,Clifford Jiajun He,Albert M. Li,Bo He,Yang Li,Meng-Ning Zhou,Jiangbin Ye

DOI: https://doi.org/10.1158/1541-7786.24229816.v1

2023-01-01

Abstract:S8. Mitochondrial uncoupling inhibits proliferation upon anchorage-independent growth.
Abstract 3695: Mitochondrial Uncoupling Reverses Reductive Carboxylation in Cancer

Haowen Jiang,Clifford Jiajun He,Albert M. Li,Bo He,Yang Li,Jiangbin Ye

DOI: https://doi.org/10.1158/1538-7445.am2023-3695

IF: 11.2

2023-01-01

Cancer Research

Abstract:Abstract When electron transport chain (ETC) activity is inhibited upon hypoxia or when cultured in suspension, reductive carboxylation plays an essential role in supporting tumor growth through converting α-ketoglutarate (α-KG) to citrate, which is converted to acetyl-coenzyme A (acetyl-CoA) for lipogenesis. However, there is no effective way to target reductive carboxylation for tumor therapy. In this study, we use the mitochondrial uncoupler niclosamide ethanolamine (NEN) and BAM15 to reverse reductive carboxylation in cancer cells. Uncoupler treatment activates ETC and increases the cellular NAD+/NADH ratio. Using U-13C-glutamine and 1-13C-glutamine tracers, we discovered that uncoupler treatment accelerates the oxidative TCA cycle and blocks reductive carboxylation, particularly under hypoxia and spheroid culture condition. Uncoupler treatment significantly reduces tumor cell proliferation, survival and sphere formation. In addition, the intracellular acetyl-CoA levels are significantly decreased by NEN treatment. Furthermore, lipidomics analysis showed that NEN treatment reduced fatty acid abundance and altered the lipid composition under both normoxia and hypoxia. Together, these data demonstrate mitochondrial uncoupling redirects the α-KG flux from reductive carboxylation back to the oxidative TCA cycle, highlighting that the ETC activity and NAD+/NADH ratio is the key switch that determines the metabolic fate of α-KG. Reversing reductive carboxylation could be one key mechanism that mitochondrial uncoupler inhibits tumor growth. Citation Format: Haowen Jiang, Clifford Jiajun He, Albert M. Li, Bo He, Yang Li, Jiangbin Ye. Mitochondrial uncoupling reverses reductive carboxylation in cancer. [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 3695.
Data from Mitochondrial Uncoupling Inhibits Reductive Carboxylation in Cancer Cells

Albert Li

DOI: https://doi.org/10.1158/1541-7786.mcr-23-0049

2023-01-01

Molecular Cancer Research

Abstract:Abstract When the electron transport chain (ETC) function is impaired, cancer cells rely on reductive carboxylation (RC) to convert α-ketoglutarate (αKG) to citrate for macromolecular synthesis, thereby promoting tumor growth. Currently, there is no viable therapy to inhibit RC for cancer treatment. In this study, we demonstrate that the mitochondrial uncoupler treatment effectively inhibits RC in cancer cells. Mitochondrial uncoupler treatment activates the ETC and increases the NAD+/NADH ratio. Using U–13C-glutamine and 1–13C-glutamine tracers, we show that mitochondrial uncoupling accelerates the oxidative tricarboxylic acid (TCA) cycle and blocks RC under hypoxia, in von Hippel-Lindau (VHL) tumor suppressor–deficient kidney cancer cells, or under anchorage-independent growth condition. Together, these data demonstrate that mitochondrial uncoupling redirects α-KG from RC back to the oxidative TCA cycle, highlighting that the NAD+/NADH ratio is one key switch that determines the metabolic fate of α-KG. Inhibiting RC could be a key mechanism by which mitochondrial uncouplers inhibit tumor growth. Implications: Mitochondrial uncoupling is a novel strategy to target RC in cancer.
Supplementary Figure from Disrupting the MYC-TFEB Circuit Impairs Amino Acid Homeostasis and Provokes Metabolic Anergy

Mario R. Fernandez,Franz X. Schaub,Chunying Yang,Weimin Li,Seongseok Yun,Stephanie K. Schaub,Frank C. Dorsey,Min Liu,Meredith A. Steeves,Andrea Ballabio,Alexandar Tzankov,Zhihua Chen,John M. Koomen,Anders E. Berglund,John L. Cleveland

DOI: https://doi.org/10.1158/0008-5472.22431502

2023-01-01

Abstract:Supplementary Figure from Disrupting the MYC-TFEB Circuit Impairs Amino Acid Homeostasis and Provokes Metabolic Anergy
Supplementary Figure 1 from Determination of the Role of Target Tissue Metabolism in Lung Carcinogenesis Using Conditional Cytochrome <i>p</i>450 Reductase-Null Mice

Wei Yan,Cheng Fang,Robert J. Turesky,Melissa Behr,Laurence S. Kaminsky,Xinxin Ding

DOI: https://doi.org/10.1158/0008-5472.22368285.v1

2023-01-01

Abstract:Supplementary Figure 1 from Determination of the Role of Target Tissue Metabolism in Lung Carcinogenesis Using Conditional Cytochrome P450 Reductase-Null Mice
Oxidation of Alpha-Ketoglutarate is Required for Reductive Carboxylation in Cancer Cells with Mitochondrial Defects.

Andrew R. Mullen,Zeping Hu,Xiaolei Shi,Lei Jiang,Lindsey K. Boroughs,Zoltan Kovacs,Richard Boriack,Dinesh Rakheja,Lucas B. Sullivan,W. Marston Linehan,Navdeep S. Chandel,Ralph J. DeBerardinis

DOI: https://doi.org/10.1016/j.celrep.2014.04.037

IF: 8.8

2014-01-01

Cell Reports

Abstract:Mammalian cells generate citrate by decarboxylating pyruvate in the mitochondria to supply the tricarboxylic acid (TCA) cycle. In contrast, hypoxia and other impairments of mitochondrial function induce an alternative pathway that produces citrate by reductively carboxylating α-ketoglutarate (AKG) via NADPH-dependent isocitrate dehydrogenase (IDH). It is unknown how cells generate reducing equivalents necessary to supply reductive carboxylation in the setting of mitochondrial impairment. Here, we identified shared metabolic features in cells using reductive carboxylation. Paradoxically, reductive carboxylation was accompanied by concomitant AKG oxidation in the TCA cycle. Inhibiting AKG oxidation decreased reducing equivalent availability and suppressed reductive carboxylation. Interrupting transfer of reducing equivalents from NADH to NADPH by nicotinamide nucleotide transhydrogenase increased NADH abundance and decreased NADPH abundance while suppressing reductive carboxylation. The data demonstrate that reductive carboxylation requires bidirectional AKG metabolism along oxidative and reductive pathways, with the oxidative pathway producing reducing equivalents used to operate IDH in reverse.
Reprogramming the Neuroblastoma Epigenome with a Mitochondrial Uncoupler

Haowen Jiang,Rachel L Greathouse,Bo He,Yang Li,Albert M. Li,Balint Forgo,Michaela Yip,Allison Li,Moriah Shih,Selene Banuelos,Meng-Ning Zhou,Joshua J. Gruber,Hiroyuki Shimada,Bill Chiu,Jiangbin Ye

DOI: https://doi.org/10.1101/2021.09.05.459035

2021-01-01

Abstract:Dysregulated DNA methylation is associated with poor prognosis in cancer patients, promoting tumorigenesis and therapeutic resistance[1][1]. DNA methyltransferase inhibitors (DNMTi) reduce DNA methylation and promote cancer cell differentiation, with two DNMTi already approved for cancer treatment[2][2]. However, these drugs rely on cell division to dilute existing methylation, thus the ‘demethylation’ effects are achieved in a passive manner, limiting their application in slow-proliferating tumor cells. In this study we use a mitochondrial uncoupler, niclosamide ethanolamine (NEN), to actively achieve global DNA demethylation. NEN treatment promotes DNA demethylation by activating electron transport chain (ETC) to produce α-ketoglutarate (α-KG), a substrate for the DNA demethylase TET. In addition, NEN inhibits reductive carboxylation, a key metabolic pathway to support growth of cancer cells with defective mitochondria or under hypoxia. Importantly, NEN treatment reduces 2-hydroxyglutarate (2-HG) generation and blocks DNA hypermethylation under hypoxia. Together, these metabolic reprogramming effects of NEN actively alter the global DNA methylation landscape and promote neuroblastoma differentiation. These results not only support Warburg’s original hypothesis that inhibition of ETC causes cell de-differentiation and tumorigenesis, but also suggest that mitochondrial uncoupling is an effective metabolic and epigenetic intervention that remodels the tumor epigenome for better prognosis.### Competing Interest StatementThe authors have declared no competing interest. [1]: #ref-1 [2]: #ref-2
Inhibiting Neddylation Modification Alters Mitochondrial Morphology and Reprograms Energy Metabolism in Cancer Cells.

Qiyin Zhou,Hua Li,Yuanyuan Li,Mingjia Tan,Shaohua Fan,Cong Cao,Feilong Meng,Ling Zhu,Lili Zhao,Min-Xin Guan,Hongchuan Jin,Yi Sun

DOI: https://doi.org/10.1172/jci.insight.121582

IF: 9.4958

2019-01-01

JCI Insight

Abstract:Abnormal activation of neddylation modification and dysregulated energy metabolism are frequently seen in many types of cancer cells. Whether and how neddylation modification affects cellular metabolism remains largely unknown. Here, we showed that MLN4924, a small-molecule inhibitor of neddylation modification, induces mitochondrial fission-to-fusion conversion in breast cancer cells via inhibiting ubiquitylation and degradation of fusion-promoting protein mitofusin 1 (MFN1) by SCFβ-TrCP E3 ligase and blocking the mitochondrial translocation of fusion-inhibiting protein DRP1. Importantly, MLN4924-induced mitochondrial fusion is independent of cell cycle progression, but confers cellular survival. Mass-spectrometry-based metabolic profiling and mitochondrial functional assays reveal that MLN4924 inhibits the TCA cycle but promotes mitochondrial OXPHOS. MLN4924 also increases glycolysis by activating PKM2 via promoting its tetramerization. Biologically, MLN4924 coupled with the OXPHOS inhibitor metformin, or the glycolysis inhibitor shikonin, significantly inhibits cancer cell growth both in vitro and in vivo. Together, our study links neddylation modification and energy metabolism, and provides sound strategies for effective combined cancer therapies.
Abstract 2180: Deciphering the Warburg effect: Redox is the key to tumor differentiation

Jiang Haowen,Rachel L. Greathouse,Bo He,Yang Li,Albert M. LI,Balint Forgo,Selene Banuelos,Joshua Gruber,Hiroyuki Shimada,Bill Chiu,Jiangbin Ye

DOI: https://doi.org/10.1158/1538-7445.am2022-2180

IF: 11.2

2022-01-01

Cancer Research

Abstract:Abstract It was proposed by Warburg that the cause and consequence of the Warburg effect were the injury of respiration and cell dedifferentiation, respectively. However, the underlying mechanism was unclear due to limited understanding of metabolic control of epigenetics. Inhibition of mitochondrial electron transport chain (ETC) causes reduction of NAD+/NADH ratio. Recently it was discovered that this redox stress not only drives lactate production from pyruvate to enhance the Warburg effect, but also promotes the conversion of α-ketoglutarate (αKG) to 2-hydroxyglutarate (2HG), turning the substrate of DNA demethylase TET into an inhibitor of TET, suggesting a potential link between ETC inhibition and dysregulated DNA methylation in cancer. In this study we use a mitochondrial uncoupler niclosamide ethanolamine (NEN) to block the Warburg effect and remodel cancer epigenome. NEN treatment activates ETC and accelerates glutaminolysis to produce αKG, which promotes promoter CpG island demethylation. This epigenomic reprograming not only upregulates tumor suppressor genes such as p53, inhibits N-Myc expression, but also activates neuron differentiation markers to promote differentiation in neuroblastoma cells. Hypoxia is one common microenvironmental stress existing in all solid tumor. NEN treatment reduces 2HG generation from αKG under hypoxia, highlighting its application potential in preventing DNA hypermethylation in vivo. Associated with 2HG reduction, NEN treatment also represses HIF signaling under hypoxia. In addition, NEN treatment inhibits reductive carboxylation flux. Moreover, dietary supplementation with NEN reduces orthotopic neuroblastoma growth and N-Myc expression in vivo. Together, these results validated Warburg’s hypothesis that mitochondrial respiration is the key to maintain normal differentiation. Restoring ETC activity with mitochondrial uncoupler is an effective metabolic/epigenetic therapy against neuroblastoma (Jiang et al., BioRxiv 2021). Citation Format: Jiang Haowen, Rachel L. Greathouse, Bo He, Yang Li, Albert M. LI, Balint Forgo, Selene Banuelos, Joshua Gruber, Hiroyuki Shimada, Bill Chiu, Jiangbin Ye. Deciphering the Warburg effect: Redox is the key to tumor differentiation [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 2180.
Supplementary Figures (figure S1 - S7) from SHMT2 Desuccinylation by SIRT5 Drives Cancer Cell Proliferation

Xin Yang,Zhe Wang,Xin Li,Boya Liu,Minghui Liu,Lu Liu,Shuaiyi Chen,Mengmeng Ren,Yankun Wang,Miao Yu,Bo Wang,Junhua Zou,Wei-Guo Zhu,Yuxin Yin,Wei Gu,Jianyuan Luo

DOI: https://doi.org/10.1158/0008-5472.22417766.v1

2023-01-01

Abstract:Figure S1 shows the SIRT5 interaction network and SHMT2 identification. Figure S2 shows that SIRT5 is irreplaceable for cancer cell in response to serine deprivation. Figure S3 shows that SIRT5 desuccinylates SHMT2. Figure S4 shows that SIRT5 upregulates SHMT2 enzymatic activity under metabolic stress. Figure S5 shows that K280 is the major succinylation site of SHMT2. Figure S6 shows that succinylation of SHMT2 at K280 restrains cellular redox balance and clonogenic growth. Figure S7 shows that succinylation of SHMT2 at K280 impairs tumor cell growth in vivo and in vitro
Mitochondria-ER contact mediated by MFN2-SERCA2 interaction supports CD8 + T cell metabolic fitness and function in tumors

Jie-Feng Yang,Xudong Xing,Li Luo,Xin-Wei Zhou,Jian-Xiong Feng,Kang-Bo Huang,Huashan Liu,Shanzhao Jin,Yi-Na Liu,Shi-Hui Zhang,Yi-Hui Pan,Bing Yu,Jin-Yu Yang,Yu-Lu Cao,Yun Cao,Cliff Y Yang,Yuan Wang,Yuxia Zhang,Jiang Li,Xiaojun Xia,Tiebang Kang,Rui-Hua Xu,Ping Lan,Jun-Hang Luo,Hui Han,Fan Bai,Song Gao,Cliff Y. Yang

DOI: https://doi.org/10.1126/sciimmunol.abq2424

IF: 30.63

2023-09-23

Science Immunology

Abstract:Metabolic fitness of T cells is essential for their vitality, which is largely dependent on the behavior of the mitochondria. The nature of mitochondrial behavior in tumor-infiltrating T cells remains poorly understood. In this study, we show that mitofusin-2 (MFN2) expression is positively correlated with the prognosis of multiple cancers. Genetic ablation of Mfn2 in CD8 + T cells dampens mitochondrial metabolism and function and promotes tumor progression. In tumor-infiltrating CD8 + T cells, MFN2 enhances mitochondria–endoplasmic reticulum (ER) contact by interacting with ER-embedded Ca 2+ -ATPase SERCA2, facilitating the mitochondrial Ca 2+ influx required for efficient mitochondrial metabolism. MFN2 stimulates the ER Ca 2+ retrieval activity of SERCA2, thereby preventing excessive mitochondrial Ca 2+ accumulation and apoptosis. Elevating mitochondria-ER contact by increasing MFN2 in CD8 + T cells improves the efficacy of cancer immunotherapy. Thus, we reveal a tethering-and-buffering mechanism of organelle cross-talk that regulates the metabolic fitness of tumor-infiltrating CD8 + T cells and highlights the therapeutic potential of enhancing MFN2 expression to optimize T cell function.

immunology
Electron transport chain inhibition increases cellular dependence on purine transport and salvage

Zheng Wu,Divya Bezwada,Feng Cai,Robert C Harris,Bookyung Ko,Varun Sondhi,Chunxiao Pan,Hieu S Vu,Phong T Nguyen,Brandon Faubert,Ling Cai,Hongli Chen,Misty Martin-Sandoval,Duyen Do,Wen Gu,Yuanyuan Zhang,Yuannyu Zhang,Bailey Brooks,Sherwin Kelekar,Lauren G Zacharias,K Celeste Oaxaca,Joao S Patricio,Thomas P Mathews,Javier Garcia-Bermudez,Min Ni,Ralph J DeBerardinis

DOI: https://doi.org/10.1016/j.cmet.2024.05.014

2024-07-02

Abstract:Mitochondria house many metabolic pathways required for homeostasis and growth. To explore how human cells respond to mitochondrial dysfunction, we performed metabolomics in fibroblasts from patients with various mitochondrial disorders and cancer cells with electron transport chain (ETC) blockade. These analyses revealed extensive perturbations in purine metabolism, and stable isotope tracing demonstrated that ETC defects suppress de novo purine synthesis while enhancing purine salvage. In human lung cancer, tumors with markers of low oxidative mitochondrial metabolism exhibit enhanced expression of the salvage enzyme hypoxanthine phosphoribosyl transferase 1 (HPRT1) and high levels of the HPRT1 product inosine monophosphate. Mechanistically, ETC blockade activates the pentose phosphate pathway, providing phosphoribosyl diphosphate to drive purine salvage supplied by uptake of extracellular bases. Blocking HPRT1 sensitizes cancer cells to ETC inhibition. These findings demonstrate how cells remodel purine metabolism upon ETC blockade and uncover a new metabolic vulnerability in tumors with low respiration.
Noncanonical TCA cycle fosters canonical TCA cycle and mitochondrial integrity in acute myeloid leukemia

Atsushi Watanabe,Chartsiam Tipgomut,Haruhito Totani,Kentaro Yoshimura,Tomohiko Iwano,Hamed Bashiri,Lee Hui Chua,Chong Yang,Toshio Suda

DOI: https://doi.org/10.1111/cas.16347

IF: 5.7

2024-11-01

Cancer Science

Abstract:The noncanonical TCA cycle plays a pivotal role in fostering the canonical TCA cycle in mitochondria and protecting against ROS damage. ACLY and the noncanonical TCA cycle would be promising therapeutic targets for malignant tumors with aberrant ACLY expression and noncanonical TCA cycle activity. Cancer cells rely on mitochondrial oxidative phosphorylation (OXPHOS) and the noncanonical tricarboxylic acid (TCA) cycle. In this paper, we shed light on the vital role played by the noncanonical TCA cycle in a host‐side concession to mitochondria, especially in highly energy‐demanding malignant tumor cells. Inhibition of ATP‐citrate lyase (ACLY), a key enzyme in the noncanonical TCA cycle, induced apoptosis by increasing reactive oxygen species levels and DNA damage while reducing mitochondrial membrane potential. The mitochondrial membrane citrate transporter inhibitor, CTPI2, synergistically enhanced these effects. ACLY inhibition reduced cytosolic citrate levels and CTPI2 lowered ACLY activity, suggesting that the noncanonical TCA cycle is sustained by a positive feedback mechanism. These inhibitions impaired ATP production, particularly through OXPHOS. Metabolomic analysis of mitochondrial and cytosolic fractions revealed reduced levels of glutathione pathway‐related and TCA cycle‐related metabolite, except fumarate, in mitochondria following noncanonical TCA cycle inhibition. Despite the efficient energy supply to the cell by mitochondria, this symbiosis poses challenges related to reactive oxygen species and mitochondrial maintenance. In conclusion, the noncanonical TCA cycle is indispensable for the canonical TCA cycle and mitochondrial integrity, contributing to mitochondrial domestication.

oncology
Mitochondrial SENP2 Regulates the Assembly of SDH Complex under Metabolic Stress

Ying Liu,Kejia Liu,Rick F. Thorne,Ronghua Shi,Qingyuan Zhang,Mian Wu,Lianxin Liu

DOI: https://doi.org/10.1016/j.celrep.2023.112041

IF: 8.8

2023-01-01

Cell Reports

Abstract:Succinate dehydrogenase (SDH) is a heterotetrameric enzyme complex belonging to the mitochondrial respiratory chain and uniquely links the tricarboxylic acid (TCA) cycle with oxidative phosphorylation. Cancer-related SDH mutations promote succinate accumulation, which is regarded as an oncometabolite. Post-translational modifications of SDH complex components are known to regulate SDH activity, although the contribution of SUMOylation remains unclear. Here, we show that SDHA is SUMOylated by PIAS3 and deSUMOylated by SENP2, events dictating the assembly and activity of the SDH complex. Moreover, CBP acetylation of SENP2 negatively regulates its deSUMOylation activity. Under glutamine deprivation, CBP levels decrease, and the ensuing SENP2 activation and SDHA deSUMOylation serve to concurrently dampen the TCA cycle and electron transport chain (ETC) activity. Along with succinate accumulation, this mechanism avoids excessive reactive oxygen species (ROS) production to promote cancer cell survival. This study elucidates a major function of mitochondrial-localized SENP2 and expands our understanding of the role of SUMOylation in resolving metabolic stress.
Nicotinamide nucleotide transhydrogenase regulates mitochondrial metabolism in NSCLC through maintenance of Fe-S protein function

Nathan P. Ward,Yun Pyo Kang,Aimee Falzone,Theresa A. Boyle,Gina M. DeNicola

DOI: https://doi.org/10.1084/jem.20191689

2020-03-20

Abstract:Human lung tumors exhibit robust and complex mitochondrial metabolism, likely precipitated by the highly oxygenated nature of pulmonary tissue. As ROS generation is a byproduct of this metabolism, reducing power in the form of nicotinamide adenine dinucleotide phosphate (NADPH) is required to mitigate oxidative stress in response to this heightened mitochondrial activity. Nicotinamide nucleotide transhydrogenase (NNT) is known to sustain mitochondrial antioxidant capacity through the generation of NADPH; however, its function in non-small cell lung cancer (NSCLC) has not been established. We found that NNT expression significantly enhances tumor formation and aggressiveness in mouse models of lung tumor initiation and progression. We further show that NNT loss elicits mitochondrial dysfunction independent of substantial increases in oxidative stress, but rather marked by the diminished activities of proteins dependent on resident iron-sulfur clusters. These defects were associated with both NADPH availability and ROS accumulation, suggesting that NNT serves a specific role in mitigating the oxidation of these critical protein cofactors.

immunology,medicine, research & experimental
Figure S5 from The Imipridone ONC213 Targets α-Ketoglutarate Dehydrogenase to Induce Mitochondrial Stress and Suppress Oxidative Phosphorylation in Acute Myeloid Leukemia

Yongwei Su,Jenna L. Carter,Xinyu Li,Yu Fukuda,Ashley Gray,John Lynch,Holly Edwards,Jun Ma,Patrick Schreiner,Lisa Polin,Juiwanna Kushner,Sijana H. Dzinic,Steven A. Buck,Shondra M. Pruett-Miller,Katie Hege-Hurrish,Camenzind Robinson,Xinan Qiao,Shuang Liu,Shuangshuang Wu,Guan Wang,Jing Li,Joshua E. Allen,Varun V. Prabhu,Aaron D. Schimmer,Dhananjay Joshi,Shiva Kalhor-Monfared,Iain D. G. Watson,Richard Marcellus,Methvin B. Isaac,Rima Al-awar,Jeffrey W. Taub,Hai Lin,John D. Schuetz,Yubin Ge

DOI: https://doi.org/10.1158/0008-5472.25515730.v1

2024-01-01

Abstract:Supplementary Figure S5
Supplementary Figures from <i>pdss2</i> Deficiency Induces Hepatocarcinogenesis by Decreasing Mitochondrial Respiration and Reprogramming Glucose Metabolism

Yan Li,Shuhai Lin,Lei Li,Zhi Tao,Yuanliang Hu,Xiaohua Ban,Tingting Zeng,Ying Zhao,Yuelong Zhu,Song Gao,Wen Dong,Xiaoshi Zhang,Dan Xie,Yufeng Yuan,Peng Huang,Jinjun Li,Zongwei Cai,Xin‐Yuan Guan

DOI: https://doi.org/10.1158/0008-5472.22417167.v1

2023-01-01

Abstract:Supplementary figure 1. PDSS2 and CoQ10 in HCC tissues and cell lines. Supplementary figure 2. PDSS2 reintroduction enhanced mitochondrial respiration. Supplementary figure 3. PDSS2 reintroduction inhibited tumor cell growth. Supplementary figure 4. PDSS2 arrested cell cycle and inhibited xenograft growth in vivo. Supplementary figure 5. PDSS2 deficiency was established in MIHA cells. Supplementary figure 6. PDSS2 deficiency affected cell growth. Supplementary figure 7. PDSS2 variants and sequence analysis of PDSS2 and PDSS2-Del2.
Supplementary Data from Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma

Haowen Jiang,Rachel L. Greathouse,Sarah Jane Tiche,Man Zhao,Bo He,Yang Li,Albert M. Li,Balint Forgo,Michaela Yip,Allison Li,Moriah Shih,Selene Banuelos,Meng-Ning Zhou,Joshua J. Gruber,Erinn B. Rankin,Zhen Hu,Hiroyuki Shimada,Bill Chiu,Jiangbin Ye

DOI: https://doi.org/10.1158/0008-5472.can-22-1029

IF: 11.2

2023-01-01

Cancer Research

Abstract:Regional counting of differential methylated probes in SK-N-BE(2) cells treated with NEN for 24hrs under nomoxia. Go enrichment pathways of the differential methylated probes of the CpG Island in the promoter (B) (C) and gene body (D) (E)
Mitochondrial isocitrate dehydrogenase impedes CAR T cell function by restraining antioxidant metabolism and histone acetylation

Xiaohui Si,Mi Shao,Xinyi Teng,Yue Huang,Ye Meng,Longyuan Wu,Jieping Wei,Lianxuan Liu,Tianning Gu,Junzhe Song,Ruirui Jing,Xingyuan Zhai,Xin Guo,Delin Kong,Xiujian Wang,Bohan Cai,Ying Shen,Zhaoru Zhang,Dongrui Wang,Yongxian Hu,Pengxu Qian,Gang Xiao,He Huang

DOI: https://doi.org/10.1016/j.cmet.2023.12.010

IF: 29

2024-01-04

Cell Metabolism

Abstract:Metabolic adaptation results in skewed differentiation with reduced anti-tumor function of T cells. Si et al. identify that IDH2 limits pentose phosphate pathway activity and cytosolic citrate availability to impede memory CAR T cell formation. Pharmacological IDH2 inhibition enhances metabolic fitness and efficacy of CAR T cells, particularly under nutrient-restricted conditions.

cell biology,endocrinology & metabolism

Supplemental Figure 2 from Mitochondrial Uncoupling Inhibits Reductive Carboxylation in Cancer Cells

Supplemental Figure 5 from Mitochondrial Uncoupling Inhibits Reductive Carboxylation in Cancer Cells

Supplemental Figure 8 from Mitochondrial Uncoupling Inhibits Reductive Carboxylation in Cancer Cells

Abstract 3695: Mitochondrial Uncoupling Reverses Reductive Carboxylation in Cancer

Data from Mitochondrial Uncoupling Inhibits Reductive Carboxylation in Cancer Cells

Supplementary Figure from Disrupting the MYC-TFEB Circuit Impairs Amino Acid Homeostasis and Provokes Metabolic Anergy

Supplementary Figure 1 from Determination of the Role of Target Tissue Metabolism in Lung Carcinogenesis Using Conditional Cytochrome &lt;i&gt;p&lt;/i&gt;450 Reductase-Null Mice

Oxidation of Alpha-Ketoglutarate is Required for Reductive Carboxylation in Cancer Cells with Mitochondrial Defects.

Reprogramming the Neuroblastoma Epigenome with a Mitochondrial Uncoupler

Inhibiting Neddylation Modification Alters Mitochondrial Morphology and Reprograms Energy Metabolism in Cancer Cells.

Abstract 2180: Deciphering the Warburg effect: Redox is the key to tumor differentiation

Supplementary Figures (figure S1 - S7) from SHMT2 Desuccinylation by SIRT5 Drives Cancer Cell Proliferation

Mitochondria-ER contact mediated by MFN2-SERCA2 interaction supports CD8 + T cell metabolic fitness and function in tumors

Electron transport chain inhibition increases cellular dependence on purine transport and salvage

Noncanonical TCA cycle fosters canonical TCA cycle and mitochondrial integrity in acute myeloid leukemia

Mitochondrial SENP2 Regulates the Assembly of SDH Complex under Metabolic Stress

Nicotinamide nucleotide transhydrogenase regulates mitochondrial metabolism in NSCLC through maintenance of Fe-S protein function

Figure S5 from The Imipridone ONC213 Targets α-Ketoglutarate Dehydrogenase to Induce Mitochondrial Stress and Suppress Oxidative Phosphorylation in Acute Myeloid Leukemia

Supplementary Figures from &lt;i&gt;pdss2&lt;/i&gt; Deficiency Induces Hepatocarcinogenesis by Decreasing Mitochondrial Respiration and Reprogramming Glucose Metabolism

Supplementary Data from Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma

Mitochondrial isocitrate dehydrogenase impedes CAR T cell function by restraining antioxidant metabolism and histone acetylation

Supplementary Figure 1 from Determination of the Role of Target Tissue Metabolism in Lung Carcinogenesis Using Conditional Cytochrome <i>p</i>450 Reductase-Null Mice

Supplementary Figures from <i>pdss2</i> Deficiency Induces Hepatocarcinogenesis by Decreasing Mitochondrial Respiration and Reprogramming Glucose Metabolism